Low Testosterone at First PSA Failure and Assessment of the Risk of Death in Men with Unfavorable-Risk Prostate Cancer Treated on Prospective Clinical Trials

BACKGROUND: Low testosterone at prostate cancer (PC) diagnosis has been associated with a worse prognosis. Whether this is true and how to define the best treatment approach at first PSA failure has not been elucidated and was studied. METHODS: Between 1995–2001, 58 men with unfavorable-risk PC trea...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer
Egile Nagusiak: Atkins, Katelyn M., Chen, Ming-Hui, Wu, Jing, Renshaw, Andrew A., Loffredo, Marian, Kantoff, Philip W., Small, Eric J., D’Amico, Anthony V.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2017
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6034656/
https://ncbi.nlm.nih.gov/pubmed/29266181
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.31204
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak